TY  - JOUR
AU  - Aliaga-Gaspar, Pablo
AU  - Hurtado-Guerrero, Isaac
AU  - Ciano-Petersen, Nicolas Lundahl
AU  - Urbaneja, Patricia
AU  - Brichette-Mieg, Isabel
AU  - Reyes, Virginia
AU  - Rodriguez-Bada, Jose Luis
AU  - Alvarez-Lafuente, Roberto
AU  - Arroyo, Rafael
AU  - Quintana, Ester
AU  - Ramio-Torrenta, Lluis
AU  - Alonso, Ana
AU  - Leyva, Laura
AU  - Fernandez, Oscar
AU  - Oliver-Martos, Begona
PY  - 2021
DO  - 10.3389/fimmu.2021.778204
SN  - 1664-3224
UR  - https://hdl.handle.net/10668/24480
T2  - Frontiers in immunology
AB  - PurposeInterferon beta receptor 2 subunit (IFNAR2) can be produced as a transmembrane protein, but also as a soluble form (sIFNAR2) generated by alternative splicing or proteolytic cleavage, which has both agonist and antagonist activities for...
LA  - en
PB  - Frontiers media sa
KW  - alternative splicing
KW  - soluble receptors
KW  - IFNAR
KW  - interferon beta
KW  - multiple sclerosis
KW  - I interferon receptor
KW  - Ifnar-2
KW  - Serum
KW  - Validation
KW  - Cytokines
KW  - Subunit
TI  - Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
TY  - research article
VL  - 12
ER  -